Burns, TN, United States of America

Robert F Mayol


Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Durham, CT (US) (1992 - 2000)
  • Burns, TN (US) (2004)

Company Filing History:


Years Active: 1992-2004

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Robert F. Mayol: Innovator in Psychopharmacology

Introduction: Robert F. Mayol, an accomplished inventor based in Burns, TN, has made significant strides in the field of psychopharmacology. With a total of five patents to his name, Mayol's contributions focus primarily on innovative treatments for anxiety, depression, and other psychogenic disorders.

Latest Patents: Among his latest inventions are two notable patents concerning the stereoisomers of 6-hydroxy-buspirone. The first, the S-6-hydroxy-buspirone, is recognized for its effectiveness in treating anxiety and depression, while potentially reducing adverse effects and providing a longer duration of action compared to conventional treatments. The second invention, R-6-hydroxy-buspirone, offers greater receptor specificity over the S-isomer, suggesting a reduced risk of adverse effects associated with its racemic mixture. These advancements highlight Mayol's dedication to enhancing therapeutic options in mental health.

Career Highlights: Robert F. Mayol is part of the Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work here emphasizes his commitment to developing innovative treatment solutions through rigorous research and application of pharmacological principles.

Collaborations: Throughout his career, Mayol has collaborated with esteemed colleagues including Joseph P. Yevich and Jianqing Li. These partnerships reflect a collaborative spirit that is often essential in the field of medical research and innovation.

Conclusion: Robert F. Mayol stands out as a notable inventor whose work has the potential to transform the treatment landscape for psychogenic disorders. His recent patents not only underline his innovative approach but also exemplify the importance of collaboration in achieving breakthroughs in pharmacological research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…